Pharma Stock Declares Record Date For Dividend To Investors, Hits 52-Week High

Mid cap pharmaceuticals sector stock, Ajanta Pharma Ltd on Friday fixed August 4, 2023 as the record date for interim dividend. Soon after the announcement, Ajanta Pharma shares hit new 52-week high. Ajanta Pharma shares have been maintaining an upward trend in last 1 week with the gain of 14%. It has declared 22 dividends since September 5, 2001 and has a dividend yield of 0.43%. Check details below:

Ajanta Pharma Declares Record Date For Dividend: According to the BSE filing of the company, "Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the record date for taking record of the Members of the Company for the purpose of determination of shareholders to whom interim dividend would be payable would be Friday, 4th August 2023."

Ajanta Pharma Dividend History: The company declared 22 dividends since 2001. The company for the quarter ended March 2023 announced an equity dividend of 350.00% or Rs 7/share. If the current Ajanta Pharma share price of Rs 1612.85 is taken into perspective, it gives shareholders a dividend yield of 0.43%.

Ajanta Pharma Stock Outlook & Return: Last trading price of Ajanta Pharma stock is Rs 1612.85 apiece with intraday gain of 4.31%. Its 52-week high price is Rs 1735.10 per share and 52-week low price is Rs 1115.15 apiece, respectively. It has a market capitalisation of Rs 20,308.31 crore. Ajanta Pharma stock rallied 36% in last 6-months, offered 27% return in last 1-year, soared 68% in last 3-years, and delivered a return of 121% in last 5-years. In last 10 years, Ajanta Pharma stock jumped 785%.

Ajanta Pharma Financial Performance: The company for the quarter ended March 31, 2023 declared its consolidated total income at Rs 918.67 crore, down 8.74 crore from last quarter total income of Rs 1006.70 crore. Its recent net profit after tax is declared at Rs 122.25 crore.

Ajanta Pharma About: Ajanta Pharma is a specialty pharmaceutical company providing quality medicines across 30+ countries in the world. Ajanta Pharma operates 7 state-of-the-art manufacturing facilities in India. Out of this, 6 facilities manufacture finished formulations and 1 manufactures Active Pharmaceutical Ingredients (APIs), primarily for captive consumption.

Disclaimer: The stock just highlights the dividend and is not a recommendation to buy, sell or hold. We have not done fundamental or technical analysis and have no opinion on the stock mentioned. Neither, the author nor Greynium Information Technologies should be held liable for ay losses. Please consult a professional advisor.